Stay updated on Fevipiprant in COPD With Eosinophilia Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant in COPD With Eosinophilia Clinical Trial page.

Latest updates to the Fevipiprant in COPD With Eosinophilia Clinical Trial page
- CheckyesterdayChange DetectedThe record now displays details for the fevipiprant COPD study, including its terminated status, study design, eligibility criteria, outcomes, and supporting documents.SummaryDifference48%

- Check8 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA sitewide banner announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the usual content, indicating access is blocked and the normal page cannot be viewed.SummaryDifference18%

- Check57 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a new version of the study record.SummaryDifference0.1%

Stay in the know with updates to Fevipiprant in COPD With Eosinophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant in COPD With Eosinophilia Clinical Trial page.